Your browser doesn't support javascript.
loading
Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence.
Esfahanian, Niki; Chan, Sze Wah Samuel; Zhan, Luna J; Brown, M Catherine; Khan, Khaleeq; Lee, Jae; Balaratnam, Karmugi; Yan, Elizabeth; Parker, Jennifer; Garcia-Pardo, Miguel; Barghout, Samir H; Eng, Lawson; Bradbury, Penelope A; Shepherd, Frances A; Leighl, Natasha B; Sacher, Adrian G; Snow, Stephanie; Juergens, Rosalyn; Liu, Geoffrey.
Afiliação
  • Esfahanian N; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada. Electronic address: niki.esfahanian@mail.utoronto.ca.
  • Chan SWS; Juravinski Cancer Centre, McMaster University, Hamilton, Canada.
  • Zhan LJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Brown MC; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Khan K; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Lee J; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Balaratnam K; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Yan E; Juravinski Cancer Centre, McMaster University, Hamilton, Canada.
  • Parker J; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Garcia-Pardo M; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Medical Oncology, Hospital Ramon y Cajal, Madrid, Spain.
  • Barghout SH; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Eng L; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Bradbury PA; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Shepherd FA; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Leighl NB; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Sacher AG; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Snow S; QEII Hospital, Dalhousie University, Halifax, Canada.
  • Juergens R; Juravinski Cancer Centre, McMaster University, Hamilton, Canada.
  • Liu G; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Epidemiology, Dalla Lana School of Public Health, Departments of Medical Biophysics, Pharmacology and Toxicology, and Institute of Medical Science, Univer
Cancer Treat Res Commun ; 37: 100774, 2023.
Article em En | MEDLINE | ID: mdl-37979334
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article